US FDA approves FARXIGA™ (dapagliflozin) tablets for the treatment of adult patients with type 2 diabetes
In clinical trials, new once-daily FARXIGA, in addition to diet and exercise, improved glycaemic control by removing glucose from the body
In clinical trials, new once-daily FARXIGA, in addition to diet and exercise, improved glycaemic control by removing glucose from the body